DK32786A - Anvendelse af dipeptidderivater til fremstilling af laegemidler til behandling af posttraumatiske nerveskader - Google Patents

Anvendelse af dipeptidderivater til fremstilling af laegemidler til behandling af posttraumatiske nerveskader Download PDF

Info

Publication number
DK32786A
DK32786A DK32786A DK32786A DK32786A DK 32786 A DK32786 A DK 32786A DK 32786 A DK32786 A DK 32786A DK 32786 A DK32786 A DK 32786A DK 32786 A DK32786 A DK 32786A
Authority
DK
Denmark
Prior art keywords
treatment
stands
hydrogen atom
dipeptide derivatives
posttraumatic
Prior art date
Application number
DK32786A
Other languages
English (en)
Other versions
DK165733B (da
DK32786D0 (da
DK165733C (da
Inventor
Hubert Giertz
Hans Barth
Leopold Flohe
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of DK32786D0 publication Critical patent/DK32786D0/da
Publication of DK32786A publication Critical patent/DK32786A/da
Publication of DK165733B publication Critical patent/DK165733B/da
Application granted granted Critical
Publication of DK165733C publication Critical patent/DK165733C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • A61K38/066TRH, thyroliberin, thyrotropin releasing hormone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK032786A 1985-01-23 1986-01-22 Anvendelse af dipeptiderivater til fremstilling a f laegemidler til forhindring eller behandling af posttraumatiske nerveskader efter ved uheld fremkaldte rygmarvs- og/eller hjernetraumer. DK165733C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853502041 DE3502041A1 (de) 1985-01-23 1985-01-23 Verwendung von dipeptidderivaten zur behandlung posttraumatischer nervenschaeden
DE3502041 1985-01-23

Publications (4)

Publication Number Publication Date
DK32786D0 DK32786D0 (da) 1986-01-22
DK32786A true DK32786A (da) 1986-07-24
DK165733B DK165733B (da) 1993-01-11
DK165733C DK165733C (da) 1993-06-07

Family

ID=6260477

Family Applications (1)

Application Number Title Priority Date Filing Date
DK032786A DK165733C (da) 1985-01-23 1986-01-22 Anvendelse af dipeptiderivater til fremstilling a f laegemidler til forhindring eller behandling af posttraumatiske nerveskader efter ved uheld fremkaldte rygmarvs- og/eller hjernetraumer.

Country Status (11)

Country Link
US (1) US4906614A (da)
EP (1) EP0188810B1 (da)
JP (1) JPS61172828A (da)
AT (1) ATE57834T1 (da)
AU (1) AU578999B2 (da)
DE (2) DE3502041A1 (da)
DK (1) DK165733C (da)
IE (1) IE58805B1 (da)
IL (1) IL77218A (da)
SG (1) SG83791G (da)
ZA (1) ZA859187B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988007867A1 (fr) * 1987-04-08 1988-10-20 Nippon Shinyaku Co., Ltd. Nootropique
US5686420A (en) * 1987-06-05 1997-11-11 Georgetown University Thyrotropin-releasing hormone analogs and method of use
JPS63316724A (ja) * 1987-06-19 1988-12-26 Nippon Shinyaku Co Ltd 抗けいれん剤
US5049553A (en) * 1990-01-04 1991-09-17 E. R. Squibb & Sons, Inc. Method for preventing or treating symptoms resulting from closed head injuries employing an ace inhibitor
JPH09509404A (ja) 1993-12-23 1997-09-22 オークランド ユニサービシズ リミテッド 神経アウトカムを改良するための組成物及び方法
US6812208B2 (en) 1993-12-23 2004-11-02 Neuronz Ltd. Methods to improve neural outcome
US5897858A (en) 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
US6187906B1 (en) * 1997-08-11 2001-02-13 Aukland Uniservices Limited Methods to improve neural outcome
US6475989B1 (en) 1997-10-09 2002-11-05 Albert Sattin Use of pyroglutamyl-glutamyl-prolyl amide (EEP) for neurological and neurobehavioral disorders
US20020151502A1 (en) * 1997-10-09 2002-10-17 Albert Sattin Tri-peptides for neurological and neurobehavior applications
US20050233973A1 (en) * 1997-10-09 2005-10-20 Albert Sattin Tri-peptides for antidepressant applications
AU1574701A (en) * 1999-10-22 2001-04-30 Wrair Walter Reed Army Institute Of Research A pharmaceutical composition containing pglu-glu-pro-nh2 and method for treating diseases and injuries to the brain, spinal cord and retina using same
US6815425B1 (en) 1999-10-22 2004-11-09 The United States Of America As Represented By The Secretary Of The Army Pharmaceutical composition containing pGLU-GLU-PRO-NH2 and method for treating diseases and injuries to the brain, spinal cord and retina using same
IE20000240A1 (en) * 2000-02-17 2003-03-05 Trinity College Dublin TRH-like peptide derivatives
AU2001289160A1 (en) * 2000-08-24 2002-03-04 Neuronz Ltd. Gpe analogs
US7112570B2 (en) * 2000-08-24 2006-09-26 Neuren Pharmaceuticals, Ltd. GPE analogs
US7714020B2 (en) * 2001-05-24 2010-05-11 Neuren Pharmaceuticals Limited Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
AU2002303856A1 (en) 2001-05-24 2002-12-03 Neuronz Limited Gpe analogs and peptidomimetics
US20070004641A1 (en) * 2001-05-24 2007-01-04 Neuren Pharmaceuticals Limited Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamate
US7605177B2 (en) * 2001-05-24 2009-10-20 Neuren Pharmaceuticals Limited Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration
US8791117B2 (en) 2003-09-03 2014-07-29 Neuren Pharmaceuticals Limited Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals
US7462595B2 (en) * 2004-09-17 2008-12-09 Prange Jr Arthur Jergen Methods for treating cancer-related fatigue
US7713935B2 (en) * 2004-10-01 2010-05-11 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Compounds that modulate TRH actions
EP3024463B1 (en) 2013-07-25 2020-03-25 Neuren Pharmaceuticals Limited Neuroprotective bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2449167C2 (de) 1974-10-16 1984-05-24 Grünenthal GmbH, 5190 Stolberg N-Acyl-L-histidyl-L-prolinamide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE2615455C2 (de) * 1976-04-09 1985-06-20 Grünenthal GmbH, 5190 Stolberg N-Acyl-L-histidyl-L-prolin (N-substituierte)-amide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
US4608365A (en) * 1984-03-30 1986-08-26 University Of Southern California Treatment of neurologic functions

Also Published As

Publication number Publication date
DK165733B (da) 1993-01-11
IE852905L (en) 1986-07-23
EP0188810A2 (de) 1986-07-30
DK32786D0 (da) 1986-01-22
ZA859187B (en) 1986-08-27
ATE57834T1 (de) 1990-11-15
SG83791G (en) 1991-11-22
EP0188810B1 (de) 1990-10-31
IE58805B1 (en) 1993-11-17
DE3580351D1 (de) 1990-12-06
US4906614A (en) 1990-03-06
AU578999B2 (en) 1988-11-10
DK165733C (da) 1993-06-07
DE3502041A1 (de) 1986-07-24
IL77218A (en) 1990-11-05
JPS61172828A (ja) 1986-08-04
EP0188810A3 (en) 1988-09-07
JPH0584286B2 (da) 1993-12-01
AU5260186A (en) 1986-07-31

Similar Documents

Publication Publication Date Title
DK32786D0 (da) Anvendelse af dipeptidderivater til fremstilling af laegemidler til behandling af posttraumatiske nerveskader
IL88507A (en) 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them
DE3164764D1 (en) 1,1,2-triphenyl-but-1-ene derivatives, process for their manufacture and their use as pharmaceutical agents
MY100343A (en) Amide derivative and external medicament comprising same
AU8169287A (en) New diphosphonic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
DK0421561T3 (da) 24-homo-vitamin-D-derivater, fremgangsmåder til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt deres anvendelse som lægemiddel
ES2058596T3 (es) Empleo de derivados de l-carnitina en el tratamiento terapeutico de alteraciones degenerativas del sistema nervioso.
NZ194528A (en) 4-phenoxypiperidines preparation and pharmaceutical compositions containing them
IL111581A (en) Cyclic amino acid derivatives pharmaceutical compositions containing them and process for their preparation
ES2039196T3 (es) Procedimiento para preparar 4-(1,2,5,6-tetrahidro-1-alquil-3-piridinil)-2-tiazolaminas y 4-(hexahidro-1-alquil-3-piridinil)-2-tiazolaminas.
CY2055B1 (en) N-(5,6,7,8-tetrahydropyrido(2,3-D)pyrimidin-6-yl-alkanoyl)-glutamic acid derivatives
DE58904337D1 (de) Arzneimittel enthaltend nitroxyalkylamine mit amidfunktion und verfahren zur herstellung dieser verbindungen.
ES2109216T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica con actividad relajante muscular de accion central.
DE3775496D1 (de) Benzhydryloxyaethyl-piperidine-derivate, verfahren zur herstellung und pharmazeutische zusammenstellungen, die diese enthalten.
EP0228314A3 (en) Use of ethanol/amine derivatives in treating or preventing hyperlipemia
ES557149A0 (es) Un procedimiento para la preparacion de derivados peptidicos de histidinilprolinamida.
ES487631A1 (es) Procedimiento para la obtencion de hexahidro-1,4-oxazepinas
EP0334674A3 (en) Use of isoxazolinones as cerebro-active drugs
DE3665593D1 (en) Peptide immunostimulants
EP0220654A3 (en) Gonadoliberine analogues, process for preparing them, pharmaceutical composition and use
ES2058315T3 (es) Compuestos eficaces contra insuficiencia cerebral.
ES468382A1 (es) Un procedimiento de preparacion de 6-ciclopropil-1,3-dihidro-1-metil-5-fenil-2-oxo-2h-tieno(2,3-e)diazepina
FR2633292B1 (fr) Nouveaux derives de la 20,21-dinoreburnamenine substitues en 15 par un groupement amine, leur procede de preparation et les intermediaires ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les reenfermant

Legal Events

Date Code Title Description
PBP Patent lapsed